GIT2 and diabetes mellitus: To identify the effects of diabetes-related pathology on GIT2 protein–protein complex interactions, we performed selective GIT2 co-immunoprecipitation (co-IP) (with pre-immune sera as a negative control) in WT and db/db pancreatic cell lysates (Figure 10B).